How can innovations achieve the cost reductions, accelerated results, reduced risk, and increased safety that they need to make car t cell therapies practical

Adopt strategies for transitioning from a good lab process to a good clinical process to overcome significant challenges. How can challenges in scale-up and scale-out be overcome to implement fundamentally solid, repeatable, foundational process development from preclinical, to clinical, and beyond? Explore novel technologies and innovations to secure the necessary level of quality, control and certainty to inject GMP throughout the phases of drug development for Car-T therapies